Nuformix (LON:NFX) Stock Price Down 10% – Here’s Why

Nuformix plc (LON:NFX) dropped 10% during trading on Monday . The stock traded as low as GBX 0.05 ($0.00) and last traded at GBX 0.05 ($0.00). Approximately 1,986,748 shares changed hands during mid-day trading, a decline of 82% from the average daily volume of 10,762,529 shares. The stock had previously closed at GBX 0.05 ($0.00).

Nuformix Stock Down 6.3 %

The company has a current ratio of 1.12, a quick ratio of 3.35 and a debt-to-equity ratio of 1.17. The business has a fifty day simple moving average of GBX 0.05 and a two-hundred day simple moving average of GBX 0.11. The company has a market cap of £368,689.50, a PE ratio of -1.63 and a beta of 1.22.

Nuformix Company Profile

Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis.